Abstract
Over 700 causal prophylactic and radical curative antimalarial drugs have been discovered during the screening of approximately 4000 chemical compounds in rodent and simian malaria models. Causal prophylactic activity in the
Plasmodium berghei—rodent
model was demonstrated by 10 distinct groups of chemicals: 1) tetrahydrofolate dehydrogenase inhibitors, 2) naphthoquinones, 3) dihydroacridinediones, 4) tetrahydrofurans, 5) guanylhydrazones, 6) analogues of clopidol, 7) quinoline esters, 8) dibenzyltetrahydro-pyrimidines, 9) 6-aminoquinolines, 10) 8-aminoquinolines.
Of the causal prophylactic compounds, only the 6- and 8-aminoquinolines were capable of curing persistent exoerythrocytic infections of
P. cynomolgi
in rhesus monkeys. The 6-aminoquinolines were substantially less active than primaquine.
This report describes a series of 4-methyl-5-phenoxy-6-methoxy-8-aminoquinolines, which are potent blood schizontocides and radical curative drugs. The most active member of this series, 4-methyl-5-(3-trifluoromethylphenoxy)-6-methoxy-8-[(4-amino-1-methylbutyl)| amino]quinoline succinate (WR 225448), was 5 times more active than primaquine in curing persistent exoerythrocytic infections of
P. cynomolgi
in rhesus monkeys.
As a blood schizontocide, WR 225448 was effective in animal models against
P. berghei, P. cynomolgi, P. vivax,
and both drug-sensitive and drug-resistant strains of
P. falciparum.
WR 225448 was also more toxic than primaquine in rats on subacute (28-day) administration.
